US EditionNew Surgical Technique Preserves Erectile Function In Prostate Cancer Patients
- On March 24, 2025, a news release from the European Association of Urology announced a new surgical method called NeuroSAFE that helps men with prostate cancer preserve erectile function following surgery.
- Traditional prostate surgery can lead to impotence and incontinence, and surgeons often err on the side of caution by foregoing nerve sparing to ensure complete cancer removal, especially in advanced cases.
- NeuroSAFE involves extracting the prostate, flash-freezing it, and having a pathologist examine samples during surgery to determine if cancer cells are present near key nerves, allowing surgeons to then decide whether to sacrifice the nerves or leave them intact.
- According to Greg Shaw, consultant urologist at University College London Hospital, using NeuroSAFE can nearly double the number of men who avoid life-changing loss of erectile function after prostate surgery, and Ricardo Almeida-Magana, a research fellow, stated that NeuroSAFE provides certainty compared to standard methods.
- A clinical trial across five U.K. Hospitals involving 344 men found that a year after surgery, 39% of NeuroSAFE patients had no or mild erectile dysfunction compared to 23% of standard surgery patients, with NeuroSAFE not affecting incontinence risk, though researchers recommend further study to track longer-term cancer outcomes and note that NeuroSAFE is not suitable for all patients.
Insights by Ground AI
Does this summary seem wrong?
27 Articles
27 Articles
All
Left
4
Center
3
Right
2
iosconews.com+23 Reposted by 23 other sources
New Surgical Technique Preserves Erectile Function In Prostate Cancer Patients
Key Takeaways
Coverage Details
Total News Sources27
Leaning Left4Leaning Right2Center3Last UpdatedBias Distribution44% Left
Bias Distribution
- 44% of the sources lean Left
44% Left
L 44%
C 33%
R 22%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage